TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0

CUSIP: 89643QAB4

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Debt / NOTE 4.000% 4/0
Market price (% of par)
91.53%
Total 13F principal
$92,413,050
Principal change
+$84,543,000
Total reported market value
$102,285,000
Number of holders
9
Value change
+$77,481,000
Number of buys
7

Quarterly Holders Quick Answers

What is CUSIP 89643QAB4?
CUSIP 89643QAB4 identifies 89643QAB4 - TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q2 2016

As of 30 Jun 2016, TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 was held by 9 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $92,413,050 in principal (par value) of the bond. The largest 9 bondholders included DEERFIELD MANAGEMENT CO, HIGHBRIDGE CAPITAL MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, Park West Asset Management LLC, CITADEL ADVISORS LLC, GABELLI FUNDS LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, Pine River Capital Management L.P., and Wellesley Investment Advisors. This page lists 9 institutional bondholders reporting positions for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.